The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1627
ISSUE 1627
June 28, 2021
Issue 1627
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
An EUA for Sotrovimab for Treatment of COVID-19
June 28, 2021 (Issue: 1627)
The investigational monoclonal antibody sotrovimab
(VIR-7831; GSK/Vir Biotechnology) has been granted
an FDA Emergency Use Authorization (EUA) for
treatment of mild to moderate COVID-19 in patients
≥12 years old who weigh ≥40 kg and are at...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.